Drug Database
Back to search

Poland· PL-100046750

Neomycinum TZF

A neomycin product containing neomycinum, registered in Poland by Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A..

ATC A01AB08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNeomycinum TZFATCA01AB08REGISTER NO.PL-100046750PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about neomycinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

URPL (Poland)
Active substance
Neomycinum
Manufacturer
Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
Country
Poland (PL)
ATC code
A01AB08
ATC class
Neomycin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990085118

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for neomycin.

Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check neomycin against other medicinesHow interaction checks work

Neomycin · interactions on record

19 records

  • 19 moderate

Most severe, free to view

  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • StreptomycinJ01GA01moderate
  • TobramycinJ01GB01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Neomycin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All neomycin products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Portugal · Neomicina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b4431895-daef-4d13-a37a-281d907396a4
GET /v1/drugs/b4431895-daef-4d13-a37a-281d907396a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "250 mg",
  "packaging": "Rp ¦ Skasowane ¦ 6995\n100 tabl.\n05909990085118 ¦ Rp ¦ 61987\n16 tabl.",
  "substance": "Neomycini sulfas 250 mg",
  "common_name": "Neomycinum",
  "pl_product_id": "100046750",
  "pozwolenie_nr": "00851",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about neomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console